Literature DB >> 874814

Centrally mediated intestinal stimulation by morphine.

J J Stewart, N W Weisbrodt, T F Burks.   

Abstract

A study was designed to examine the effects of intraventricularly (i.vt.) administered morphine, apomorphine and epinephrine on the small intestine. Adult cats of either sex were implanted chronically with extracellular, monopolar electrodes at equal intervals along the entire small intestine. A collison cannula was placed in the left lateral cerebral ventricle in each animal. In animals that did not respond with emesis, morphine sulfate (200 micron g) administered i.vt. increased the incidence of spike potentials over the proximal three-quarters of the small intestine almost immediately. The response to i.vt. morphine was abolished by pretreatment with i.vt. naloxone HC1 (200 micron g) and was not obtained after peripheral (i.p.) injection of morphine at the same dose effective centrall. Now change in the number of spike potentials occure after i.vt. administration of two other potent emetic agents, apomorphine HC1 (200 micron g) and epinephrine HC1 (15O micron g), in animals that did not respond with emesis. The results suggest that the increased incidence of spike potentials after i.vt. morphine is a naloxone-sensitive, centrally mediated event not associated with activation of the central emetic mechanism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874814

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Nanoconjugated NAP as a Potent and Periphery Selective Mu Opioid Receptor Modulator To Treat Opioid-Induced Constipation.

Authors:  Guoyan G Xu; Olga Yu Zolotarskaya; Dwight A Williams; Yunyun Yuan; Dana E Selley; William L Dewey; Hamid I Akbarali; Hu Yang; Yan Zhang
Journal:  ACS Med Chem Lett       Date:  2016-11-21       Impact factor: 4.345

2.  Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists.

Authors:  E Beubler; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

3.  Central regulation of intestinal basal and stimulated water and ion transport by endogenous opiates in dogs.

Authors:  M P Primi; L Bueno; J Fioramonti
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

4.  Muscle innervation of the gut: structure and pathology.

Authors:  E R Howard
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

5.  Vomiting and the small intestine.

Authors:  D G Thompson; J R Malagelada
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

6.  Centrally and peripherally mediated inhibition of intestinal motility by opioids.

Authors:  R Schulz; M Wüster; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

7.  Opposite central and peripheral control by endogenous opioids of intestinal motility in fed rats.

Authors:  P J Rivière; M Liberge; D Murillo-Lopez; L Bueno
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

8.  Peristalsis in the isolated guinea-pig ileum during opiate withdrawal.

Authors:  W Kromer; R Woinoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

9.  Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.

Authors:  J P Huidobro-Toro; E L Way
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

10.  Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.

Authors:  Yunyun Yuan; Orgil Elbegdorj; Jianyang Chen; Shashidhar K Akubathini; Feng Zhang; David L Stevens; Irina O Beletskaya; Krista L Scoggins; Zhenxian Zhang; Phillip M Gerk; Dana E Selley; Hamid I Akbarali; William L Dewey; Yan Zhang
Journal:  J Med Chem       Date:  2012-11-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.